Penyakit Addison
Published on May 17, 2026
Risk Factors
Autoimmune disease (most common in developed countries), tuberculosis (most common worldwide), HIV/AIDS, adrenal hemorrhage (Waterhouse-Friderichsen syndrome in meningococcemia), metastatic cancer to adrenals, chronic anticoagulation, antiphospholipid syndrome
Etiology
Destruction of the adrenal cortex leading to deficiency of cortisol, aldosterone, and adrenal androgens. Autoimmune adrenalitis accounts for roughly 80% of cases in industrialized nations.
Presentation
Chronic fatigue, weight loss, anorexia, nausea, vomiting, abdominal pain, salt craving, postural dizziness
Classic Exam
Hyperpigmentation (skin creases, buccal mucosa, scars, nipples), hypotension/orthostatic hypotension, vitiligo (if autoimmune)
Diagnostics
Low morning cortisol, elevated ACTH, failed cortisol response on cosyntropin stimulation test, hyperkalemia, hyponatremia, non-anion gap metabolic acidosis, possible hypercalcemia and eosinophilia
Management
Hydrocortisone (glucocorticoid replacement) + Fludrocortisone (mineralocorticoid replacement); stress-dose steroids during illness or surgery
Keywords
Hyperpigmentation + hypotension, salt craving, hyperkalemia with hyponatremia, "bronze skin," Waterhouse-Friderichsen
01Pathophysiology
Addison's disease results from the progressive destruction of the adrenal cortex, which must lose approximately 90% of its functional tissue before clinical insufficiency becomes apparent. The cortex is responsible for producing three classes of hormones: glucocorticoids (cortisol) from the zona fasciculata, mineralocorticoids (aldosterone) from the zona glomerulosa, and adrenal androgens (DHEA) from the zona reticularis.
When cortisol production falls, the hypothalamic-pituitary axis loses its negative feedback. The anterior pituitary responds by increasing secretion of ACTH, which is co-cleaved from the precursor molecule proopiomelanocortin (POMC). POMC also gives rise to melanocyte-stimulating hormone (MSH), and the excess MSH is what drives the characteristic hyperpigmentation. This is the single most important pathophysiologic link to understand for exam purposes: hyperpigmentation occurs because ACTH is elevated, and ACTH elevation only happens in primary adrenal failure, not secondary (pituitary) or tertiary (hypothalamic) insufficiency.
The loss of aldosterone is what distinguishes primary from secondary adrenal insufficiency at the metabolic level. Aldosterone normally acts on the distal tubule and collecting duct to reabsorb sodium and excrete potassium and hydrogen ions. Without aldosterone, the patient develops hyponatremia, hyperkalemia, and a non-anion gap metabolic acidosis (type IV renal tubular acidosis). The sodium wasting also causes volume depletion, contributing to the hypotension and salt craving. In secondary adrenal insufficiency, aldosterone is preserved because it is regulated primarily by the renin-angiotensin-aldosterone system (RAAS), not ACTH. This is why secondary insufficiency does not cause hyperkalemia.
Cortisol deficiency itself impairs vascular tone and the body's ability to mount a stress response. During physiologic stress (infection, surgery, trauma), the adrenal glands normally increase cortisol output several-fold. A patient with Addison's disease cannot do this, which is why they are at risk for adrenal crisis, a life-threatening emergency characterized by profound hypotension, shock, fever, and altered mental status.
02Classification and Clinical Manifestation
Primary (Addison's)
Mechanism
Adrenal cortex destruction
Cortisol
Low
Aldosterone
Low
ACTH
High
Hyperpigmentation
Yes
Hyperkalemia
Yes
Secondary
Mechanism
Pituitary ACTH deficiency (tumor, surgery, Sheehan syndrome)
Cortisol
Low
Aldosterone
Normal
ACTH
Low
Hyperpigmentation
No
Hyperkalemia
No
Tertiary
Mechanism
Chronic exogenous steroid use causing hypothalamic-pituitary suppression
Cortisol
Low
Aldosterone
Normal
ACTH
Low
Hyperpigmentation
No
Hyperkalemia
No
Type | Mechanism | Cortisol | Aldosterone | ACTH | Hyperpigmentation | Hyperkalemia |
|---|---|---|---|---|---|---|
Primary (Addison's) | Adrenal cortex destruction | Low | Low | High | Yes | Yes |
Secondary | Pituitary ACTH deficiency (tumor, surgery, Sheehan syndrome) | Low | Normal | Low | No | No |
Tertiary | Chronic exogenous steroid use causing hypothalamic-pituitary suppression | Low | Normal | Low | No | No |
Clinical Manifestation
Hormone | Clinical Manifestations |
|---|---|
Cortisol deficiency | Fatigue, weakness, weight loss, anorexia, nausea, vomiting, abdominal pain, hypoglycemia (especially in children), inability to mount stress response, hypotension |
Aldosterone deficiency | Salt craving, orthostatic hypotension, hyponatremia, hyperkalemia, metabolic acidosis, volume depletion |
Androgen deficiency | Decreased axillary and pubic hair (more noticeable in women), reduced libido |
Elevated ACTH/MSH | Hyperpigmentation of palmar creases, buccal mucosa, scars, areolae, pressure points |
Adrenal crisis deserves special attention. It presents acutely with cardiovascular collapse, severe hypotension refractory to fluids and vasopressors, fever, abdominal pain mimicking an acute abdomen, altered consciousness, and severe electrolyte derangements. The most common precipitant is an intercurrent illness in a patient with undiagnosed Addison's disease, or a patient who fails to increase their steroid dose during physiologic stress.
03Diagnostic Workup
Morning serum cortisol
Role
Screening / initial test
Expected Finding
Low (< 3 mcg/dL is highly suggestive; > 18 mcg/dL essentially rules it out)
Serum ACTH
Role
Differentiate primary vs. secondary
Expected Finding
Elevated in primary, low/normal in secondary
Cosyntropin (ACTH) stimulation test
Role
Best initial diagnostic test
Expected Finding
Cortisol fails to rise above 18-20 mcg/dL at 30 or 60 minutes
Basic metabolic panel
Role
Supportive
Expected Finding
Hyperkalemia, hyponatremia, possible hypercalcemia, non-anion gap metabolic acidosis
CBC
Role
Supportive
Expected Finding
Eosinophilia (cortisol normally suppresses eosinophils)
21-hydroxylase antibodies
Role
Confirm autoimmune etiology
Expected Finding
Positive in autoimmune adrenalitis
CT abdomen (adrenals)
Role
Determine structural cause
Expected Finding
Small/atrophied adrenals (autoimmune) vs. enlarged/calcified (TB, hemorrhage, infiltration)
Test | Role | Expected Finding |
|---|---|---|
Morning serum cortisol | Screening / initial test | Low (< 3 mcg/dL is highly suggestive; > 18 mcg/dL essentially rules it out) |
Serum ACTH | Differentiate primary vs. secondary | Elevated in primary, low/normal in secondary |
Cosyntropin (ACTH) stimulation test | Best initial diagnostic test | Cortisol fails to rise above 18-20 mcg/dL at 30 or 60 minutes |
Basic metabolic panel | Supportive | Hyperkalemia, hyponatremia, possible hypercalcemia, non-anion gap metabolic acidosis |
CBC | Supportive | Eosinophilia (cortisol normally suppresses eosinophils) |
21-hydroxylase antibodies | Confirm autoimmune etiology | Positive in autoimmune adrenalitis |
CT abdomen (adrenals) | Determine structural cause | Small/atrophied adrenals (autoimmune) vs. enlarged/calcified (TB, hemorrhage, infiltration) |
The cosyntropin stimulation test is the best initial diagnostic test and the most commonly tested step. Synthetic ACTH (cosyntropin, 250 mcg IV) is administered, and serum cortisol is measured at baseline, 30 minutes, and 60 minutes. In a healthy individual, cortisol should rise to at least 18-20 mcg/dL. In primary adrenal insufficiency, the adrenal glands are destroyed and cannot respond, so cortisol remains low regardless of ACTH stimulation.
Once the cosyntropin test confirms adrenal insufficiency, you need to determine whether it is primary or secondary. This is where the plasma ACTH level becomes critical. A high ACTH with a failed cosyntropin test confirms primary disease. A low ACTH with a failed cosyntropin test points to secondary insufficiency (pituitary problem), and you would then pursue pituitary MRI.
For identifying the underlying cause in primary disease, 21-hydroxylase antibodies help confirm autoimmune adrenalitis. If antibodies are negative, CT imaging of the adrenals is warranted to look for tuberculosis (bilateral adrenal calcification is classic), hemorrhage, or infiltrative disease.
An important lab pattern to recognize on the exam: hyponatremia + hyperkalemia + metabolic acidosis + eosinophilia in a patient with hypotension and hyperpigmentation. This combination should immediately trigger consideration of Addison's disease.
04Management and Treatment
Chronic glucocorticoid replacement
Treatment
Hydrocortisone
Details
15-25 mg/day divided into 2-3 doses (typical: 10 mg morning, 5 mg afternoon, 5 mg evening; the largest dose is given in the morning to mimic physiologic diurnal rhythm)
Chronic mineralocorticoid replacement
Treatment
Fludrocortisone
Details
0.05-0.2 mg once daily
Adrenal crisis
Treatment
IV hydrocortisone
Details
100 mg IV bolus, then 50 mg IV every 6-8 hours; aggressive IV normal saline; dextrose if hypoglycemic
Stress dosing (minor illness)
Treatment
Double or triple oral hydrocortisone
Details
2-3x the daily dose for the duration of the illness
Stress dosing (major surgery)
Treatment
IV hydrocortisone
Details
100 mg IV before induction, then 50 mg every 8 hours for 24-72 hours, then taper to maintenance
Setting | Treatment | Details |
|---|---|---|
Chronic glucocorticoid replacement | Hydrocortisone | 15-25 mg/day divided into 2-3 doses (typical: 10 mg morning, 5 mg afternoon, 5 mg evening; the largest dose is given in the morning to mimic physiologic diurnal rhythm) |
Chronic mineralocorticoid replacement | Fludrocortisone | 0.05-0.2 mg once daily |
Adrenal crisis | IV hydrocortisone | 100 mg IV bolus, then 50 mg IV every 6-8 hours; aggressive IV normal saline; dextrose if hypoglycemic |
Stress dosing (minor illness) | Double or triple oral hydrocortisone | 2-3x the daily dose for the duration of the illness |
Stress dosing (major surgery) | IV hydrocortisone | 100 mg IV before induction, then 50 mg every 8 hours for 24-72 hours, then taper to maintenance |
Chronic management requires lifelong replacement of both cortisol and aldosterone. Hydrocortisone is preferred over other glucocorticoids because its short half-life allows dosing that mimics the normal diurnal cortisol curve. Prednisolone or dexamethasone can be used as alternatives, but dexamethasone has no mineralocorticoid activity and its long half-life makes physiologic dosing difficult.
Fludrocortisone replaces aldosterone. Its adequacy is monitored by checking blood pressure, serum potassium, and plasma renin activity. The goal is to normalize potassium and keep renin in the upper-normal range. Patients should be advised to maintain a liberal salt intake.
Adrenal crisis is a medical emergency. The single most important step is immediate IV hydrocortisone 100 mg before any diagnostic workup. Do not wait for lab confirmation. If the diagnosis is uncertain, dexamethasone 4 mg IV can be given instead because it does not interfere with the cosyntropin stimulation test (hydrocortisone cross-reacts with the cortisol assay, making subsequent testing uninterpretable). Aggressive volume resuscitation with isotonic saline is critical. Once the patient stabilizes, transition to oral replacement and taper to maintenance doses.
Stress dosing is a concept frequently tested. Patients must be educated to increase their glucocorticoid dose during febrile illness, trauma, or surgical procedures. Failure to stress-dose is the most common cause of adrenal crisis in a known Addison's patient. All patients should wear a medical alert bracelet and carry an emergency injectable hydrocortisone kit.
One key point: at high doses (> 50 mg/day), hydrocortisone provides adequate mineralocorticoid effect. Therefore, fludrocortisone is unnecessary during acute crisis management and can be added back once the patient is on maintenance doses.
05Differential Diagnosis and Distractors
Secondary adrenal insufficiency (pituitary failure)
Why It Is Similar
Fatigue, hypotension, low cortisol, weight loss
Key Discriminator
No hyperpigmentation (ACTH is low, not high), no hyperkalemia (aldosterone is intact), history of pituitary surgery/radiation or chronic steroid use
Hypothyroidism
Why It Is Similar
Fatigue, weight changes, weakness
Key Discriminator
No hyperpigmentation, no hyperkalemia, TSH is elevated, different metabolic profile
Hemochromatosis
Why It Is Similar
Skin darkening ("bronze diabetes")
Key Discriminator
Darkening is generalized and gray-bronze (iron deposition), not in creases/mucosa; ferritin and transferrin saturation are elevated; associated with diabetes and hepatomegaly
Pheochromocytoma
Why It Is Similar
Episodic symptoms, adrenal pathology
Key Discriminator
Causes hypertension (not hypotension), episodic headaches/palpitations/diaphoresis, elevated catecholamines
Anorexia nervosa
Why It Is Similar
Weight loss, fatigue, amenorrhea, electrolyte abnormalities
Key Discriminator
Hypokalemia (not hyperkalemia), body image distortion, no hyperpigmentation
Chronic fatigue syndrome
Why It Is Similar
Persistent fatigue, weakness
Key Discriminator
Normal cortisol, normal electrolytes, no hyperpigmentation, diagnosis of exclusion
Celiac disease / malabsorption
Why It Is Similar
Weight loss, fatigue, possible autoimmune overlap
Key Discriminator
Diarrhea and steatorrhea are prominent, anti-tTG antibodies positive, no hyperkalemia or hyperpigmentation
Nelson syndrome
Why It Is Similar
Hyperpigmentation with elevated ACTH
Key Discriminator
Occurs after bilateral adrenalectomy, pituitary macroadenoma with very high ACTH, visual field defects
Differential Diagnosis | Why It Is Similar | Key Discriminator |
|---|---|---|
Secondary adrenal insufficiency (pituitary failure) | Fatigue, hypotension, low cortisol, weight loss | No hyperpigmentation (ACTH is low, not high), no hyperkalemia (aldosterone is intact), history of pituitary surgery/radiation or chronic steroid use |
Hypothyroidism | Fatigue, weight changes, weakness | No hyperpigmentation, no hyperkalemia, TSH is elevated, different metabolic profile |
Hemochromatosis | Skin darkening ("bronze diabetes") | Darkening is generalized and gray-bronze (iron deposition), not in creases/mucosa; ferritin and transferrin saturation are elevated; associated with diabetes and hepatomegaly |
Pheochromocytoma | Episodic symptoms, adrenal pathology | Causes hypertension (not hypotension), episodic headaches/palpitations/diaphoresis, elevated catecholamines |
Anorexia nervosa | Weight loss, fatigue, amenorrhea, electrolyte abnormalities | Hypokalemia (not hyperkalemia), body image distortion, no hyperpigmentation |
Chronic fatigue syndrome | Persistent fatigue, weakness | Normal cortisol, normal electrolytes, no hyperpigmentation, diagnosis of exclusion |
Celiac disease / malabsorption | Weight loss, fatigue, possible autoimmune overlap | Diarrhea and steatorrhea are prominent, anti-tTG antibodies positive, no hyperkalemia or hyperpigmentation |
Nelson syndrome | Hyperpigmentation with elevated ACTH | Occurs after bilateral adrenalectomy, pituitary macroadenoma with very high ACTH, visual field defects |
The two most commonly confused entities on exams are primary vs. secondary adrenal insufficiency. The table below reinforces the distinction:
ACTH
Primary (Addison's)
High
Secondary (Pituitary)
Low
Aldosterone
Primary (Addison's)
Low
Secondary (Pituitary)
Normal
Hyperpigmentation
Primary (Addison's)
Present
Secondary (Pituitary)
Absent
Hyperkalemia
Primary (Addison's)
Present
Secondary (Pituitary)
Absent
Most common cause
Primary (Addison's)
Autoimmune / TB
Secondary (Pituitary)
Abrupt steroid withdrawal
Feature | Primary (Addison's) | Secondary (Pituitary) |
|---|---|---|
ACTH | High | Low |
Aldosterone | Low | Normal |
Hyperpigmentation | Present | Absent |
Hyperkalemia | Present | Absent |
Most common cause | Autoimmune / TB | Abrupt steroid withdrawal |
06Traps and High-Yield Pearls
The most common trap with Addison's disease questions is confusing primary with secondary adrenal insufficiency. Test-writers will present a patient on chronic prednisone who abruptly stops the medication and develops fatigue, hypotension, and hyponatremia. Students see "adrenal insufficiency" and jump to Addison's, but the absence of hyperkalemia and hyperpigmentation should redirect you to tertiary/secondary insufficiency from HPA axis suppression. Always check the potassium: if it is normal, this is not primary adrenal failure.
Another classic trap is the adrenal crisis scenario where the vignette buries the adrenal history and focuses on the acute presentation of shock, abdominal pain, and fever. Students anchor on sepsis, acute abdomen, or meningitis. The key trigger is unexplained hypotension refractory to fluids and vasopressors, especially with hyperkalemia and hyponatremia. In a patient with a history of autoimmune disease, tuberculosis, or steroid use, this should raise immediate concern.
The Waterhouse-Friderichsen syndrome vignette is high-yield: a child or young adult with meningococcal meningitis who develops purpura fulminans, DIC, and acute adrenal hemorrhage. This is acute primary adrenal insufficiency from bilateral adrenal hemorrhage, and the treatment is immediate IV hydrocortisone along with antibiotics and supportive care.
Remember that fludrocortisone is not needed in secondary insufficiency because aldosterone production is governed by the RAAS, which is independent of ACTH. This is tested frequently as an "unnecessary treatment" option.
Finally, the concept being tested is almost always one of three things: the ability to recognize the classic presentation (hyperpigmentation + hyperkalemia + hyponatremia + hypotension), the ability to distinguish primary from secondary causes using ACTH and potassium, or the knowledge that stress dosing is required and that failure to provide it is the most common precipitant of adrenal crisis.